Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Lantus and NPH Insulin in the Dawn Phenomenon
NCT00694122Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2005
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started Jun 2005; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00694122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694122.